Feature Channels: Alzheimer's and Dementia

Filters close
Released: 13-Feb-2024 11:05 AM EST
Life doesn't stop at age 65. Get the latest on seniors and healthy aging in the Seniors channel
Newswise

Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.

Released: 11-Feb-2024 8:05 PM EST
Language barriers could contribute to higher aggression in people with dementia
Edith Cowan University

Immigrants living with dementia were more likely to present with agitation and aggression compared with their non-immigrant counterparts, a new study by Edith Cowan University (ECU) in collaboration with The Dementia Centre, HammondCare, found.

Newswise: Using Ion Beams to Improve Brain Microscopy
5-Feb-2024 4:25 PM EST
Using Ion Beams to Improve Brain Microscopy
Biophysical Society

Improving the way scientists can see the microscopic structures of the brain can improve our understanding of a host of brain diseases, like Alzheimer’s or multiple sclerosis. Studying these diseases is challenging and has been limited by accuracy of available models.To see the smallest parts of cells, scientists often use a technique called electron microscopy.

   
Newswise: Protein Accumulation on Fat Droplets Implicated in Late-Onset Alzheimer’s Disease
Released: 9-Feb-2024 12:05 PM EST
Protein Accumulation on Fat Droplets Implicated in Late-Onset Alzheimer’s Disease
University of North Carolina School of Medicine

In an effort five years in the making, UNC School of Medicine cell biologist Sarah Cohen, PhD, and Rockefeller University’s Ian Windham, PhD, describe the interplay between fats and proteins in brain cells and how their dysfunction contributes to the development of late-onset Alzheimer’s disease.

Newswise: University Hospitals Now Offering FDA-Approved Medication for Treatment of Alzheimer’s Disease
Released: 9-Feb-2024 9:30 AM EST
University Hospitals Now Offering FDA-Approved Medication for Treatment of Alzheimer’s Disease
University Hospitals Cleveland Medical Center

University Hospitals Brain Health & Memory Center is now treating patients with LEQEMBI® (lecanemab), a Food and Drug Administration-approved medication for the treatment of Alzheimer’s disease.

8-Feb-2024 11:05 AM EST
Certain Older Americans Show Hesitation Around Brain Scan Research
Rutgers University-New Brunswick

Rutgers Health researchers find differences among Asian older adults’ support of research and inclination to receive MRI results.

2-Feb-2024 8:05 AM EST
Erectile Dysfunction Drugs May Be Linked to Reduced Risk of Alzheimer’s Disease
American Academy of Neurology (AAN)

The drugs used to treat erectile dysfunction may also be associated with a reduced risk of Alzheimer’s disease, according to a study published in the February 7, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Submonolayer Biolasers: Lower Gain, Higher Sensitivity
Released: 7-Feb-2024 9:00 AM EST
Submonolayer Biolasers: Lower Gain, Higher Sensitivity
Chinese Academy of Sciences

Designing sensitive and single-use biosensors for early diagnosis remains a major challenge. Scientists in China invented submonolayer lasers on optical fibers as ultrasensitive and disposable biosensors.

   
Released: 6-Feb-2024 12:05 PM EST
Research Team Discovers Potential Alzheimer’s Drug
University of Arkansas for Medical Sciences

A potential new drug to prevent Alzheimer’s disease in people with the so-called Alzheimer’s gene has been discovered by a University of Arkansas for Medical Sciences (UAMS) research team led by Sue Griffin, Ph.D.

Released: 6-Feb-2024 11:05 AM EST
Rutgers Professors Expand Collaboration between US and Israeli Scientists Seeking a Cure for Alzheimer's Disease
Rutgers University-New Brunswick

Two Rutgers professors, both leading Alzheimer's disease researchers, have partnered with Tel Aviv University and Hebrew University to organize the US-Israel Alzheimer’s Disease Conference in Tel Aviv.

Newswise: New study identifies gene believed to be responsible for ALS and dementia
Released: 6-Feb-2024 10:05 AM EST
New study identifies gene believed to be responsible for ALS and dementia
Case Western Reserve University

Researchers have discovered why a gene that, when mutated, is a common cause of two debilitating brain diseases.

Newswise: Could artificial intelligence help or hurt scientific research articles?
Released: 6-Feb-2024 9:30 AM EST
Could artificial intelligence help or hurt scientific research articles?
Indiana University

Since its introduction to the public in November 2022, ChatGPT, an artificial intelligence system, has substantially grown in use, creating written stories, graphics, art and more with just a short prompt from the user.

Newswise: 1920_healing-gardens-plaza-cedars-sinai-2.jpg?10000
Released: 2-Feb-2024 1:05 AM EST
Nicolas Musi, MD, Named Inaugural Cypres Chair in Diabetes Research
Cedars-Sinai

Nicolas Musi, MD, studies a spectrum of age-related disorders that can impact a healthy lifespan.

Released: 1-Feb-2024 1:05 PM EST
UW-Madison researchers first to 3D-print functional human brain tissue
University of Wisconsin–Madison

A team of University of Wisconsin–Madison scientists has developed the first 3D-printed brain tissue that can grow and function like typical brain tissue.

   
Newswise: Innovative Portable Sensors for Hydrogen Peroxide Detection Unveiled
Released: 1-Feb-2024 8:05 AM EST
Innovative Portable Sensors for Hydrogen Peroxide Detection Unveiled
Chinese Academy of Sciences

Hydrogen peroxide is crucial in cell metabolism, playing key roles in cell proliferation, differentiation, and migration. However, elevated levels of hydrogen peroxide (H2O2) are linked to several diseases, including cancer and neurodegenerative disorders like Alzheimer's and Parkinson's disease.

   
Newswise: The Medical Minute: Hearing impairment can lead to depression, isolation, dementia
Released: 31-Jan-2024 5:05 PM EST
The Medical Minute: Hearing impairment can lead to depression, isolation, dementia
Penn State Health

Left unchecked, hearing loss can lead to lead to social isolation and depression – two conditions proven to hasten dementia. A Penn State Health expert sounds off on what you can do about it.

Released: 31-Jan-2024 1:05 PM EST
RNA Scientist Receives Federal Funding to Commercialize Molecular Tool Against Alzheimer’s Disease
University at Albany, State University of New York

University at Albany scientist Scott Tenenbaum, founder of UAlbany spinoff company sxRNA Technologies, Inc. (sxRNA Tech), has received $500,000 from the National Institute on Aging, part of the National Institutes of Health, to study how aging brain cells shape the progression of Alzheimer’s disease, and advance RNA technology that could inform new therapeutics to prevent and treat Alzheimer's and related dementias.

Released: 31-Jan-2024 10:05 AM EST
UGA stroke treatment headed to clinical trial
University of Georgia

A new therapeutic for stroke based on University of Georgia research will soon enter clinical trials.

Newswise: RUDN chemists suppress overactivity of enzymes that cause Alzheimer's disease
Released: 31-Jan-2024 4:05 AM EST
RUDN chemists suppress overactivity of enzymes that cause Alzheimer's disease
Scientific Project Lomonosov

RUDN University chemists have obtained new azaheterocyclic compounds that inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), regulators of the central nervous system.

Released: 30-Jan-2024 2:05 PM EST
Our winter of discontent: Get the latest news on the flu in the Influenza channel
Newswise

The latest research and expertise on the flue can be found in the Influenza channel on Newswise.

Newswise: Residents of Rural ‘Glades’ Take a ‘Leap of Faith’ to Combat Dementia
Released: 30-Jan-2024 8:30 AM EST
Residents of Rural ‘Glades’ Take a ‘Leap of Faith’ to Combat Dementia
Florida Atlantic University

Compared to urban dwellers, racially/ethnically diverse older adults face up to an 80 percent greater risk of cognitive impairment in older age, and 2.5 times potentially preventable Alzheimer’s-related (ADRD) hospitalizations.

Released: 30-Jan-2024 6:05 AM EST
New drug reveals a key mechanism to overcome resistance to protein degraders
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

Protein degraders offer a novel approach to targeting undruggable diseases by hijacking the cell's degradation machinery.

Newswise: Re-energizing mitochondria to treat Alzheimer’s disease
Released: 29-Jan-2024 4:05 PM EST
Re-energizing mitochondria to treat Alzheimer’s disease
Scripps Research Institute

Nerve cells in the brain demand an enormous amount of energy to survive and maintain their connections for communicating with other nerve cells.

Released: 25-Jan-2024 12:05 PM EST
Study finds significant disparities in diagnosis and treatment of dementia
UC Davis Health

A new study from UC Davis Health and Oregon Health & Science University reveals significant disparities in dementia care.

Released: 23-Jan-2024 2:05 PM EST
People with dementia or other forms of cognitive impairment smile, sing, and even dance with headphones on
Quiet Events Inc.

Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.

Newswise: u.-of-i.-ph.d.-candidate-paul-bogdan-right-and-psychology-professors-florin-and-sanda-dolcos-.jpg?Status=Master&sfvrsn=136467c9_1
Released: 18-Jan-2024 2:05 PM EST
Don’t look back: the aftermath of a distressing event is more memorable than the lead-up, study suggests
Beckman Institute for Advanced Science and Technology, University of Illinois at Urbana-Champaign

A Beckman study led by Paul Bogdan and Florin and Sanda Dolcos suggests the moments that follow a distressing episode are more memorable than the moments leading up to it.

 
Newswise: Wireless Drug Patch Shows Promise as Chronic Disease Treatment Delivery System
Released: 18-Jan-2024 11:30 AM EST
Wireless Drug Patch Shows Promise as Chronic Disease Treatment Delivery System
University of North Carolina School of Medicine

This research from UNC-Chapel Hill, published in the journal Nature Communications, opens the door to researching this wirelessly controlled patch to deliver on-demand treatments for neurodegenerative disorders, including Alzheimer’s disease.

Released: 17-Jan-2024 4:05 PM EST
$24M NIH grant extends Study of Healthy Aging in African Americans (STAR)
UC Davis Health

UC Davis Health and Kaiser Permanente Division of Research received a $24 million grant from the National Institute on Aging, part of the NIH, to continue the Study of Healthy Aging in African Americans (STAR).

12-Jan-2024 12:05 PM EST
How Do Controllable Risk Factors for Dementia Vary by Race, Ethnicity?
American Academy of Neurology (AAN)

Approximately 23% of people diagnosed with Alzheimer’s disease or another related dementia in their 60s and later have cases that can be explained by controllable risk factors such as high blood pressure, diabetes, physical inactivity, and too little or too much sleep, and that percentage varies depending on race and ethnicity, according to a new study published in the January 17, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.

Newswise: Cellular clean energy: Can mitochondria make more energy without collateral damage?
Released: 12-Jan-2024 10:05 PM EST
Cellular clean energy: Can mitochondria make more energy without collateral damage?
Gladstone Institutes

Is it possible to amp up the energy production of mitochondria, the “power centers” of cells, without also boosting potentially harmful byproducts? If so, such a method could be used to treat a host of neurodegenerative diseases in which impaired mitochondria are believed to play a central role.

Released: 12-Jan-2024 9:05 PM EST
Study reveals function of little-understood synapse in the brain
Oregon Health & Science University

New research from Oregon Health & Science University for the first time reveals the function of a little-understood junction between cells in the brain that could have important treatment implications for conditions ranging from multiple sclerosis to Alzheimer’s disease, to a type of brain cancer known as glioma.

Released: 12-Jan-2024 8:05 AM EST
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Darmiyan

FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia. This breakthrough is a significant step in proactive brain health management, offering a fully non-invasive, convenient, and globally accessible screening solution, to be prioritized before other tests or treatments.

Newswise: Flagging Dementia Patients for Better Hospital Care
Released: 11-Jan-2024 11:05 AM EST
Flagging Dementia Patients for Better Hospital Care
Cedars-Sinai

Cedars-Sinai investigators are using electronic health records to identify hospitalized patients likely to have dementia. The method they developed, detailed in a study published in the peer-reviewed Journal of the American Geriatrics Society, is designed to help medical staff tailor care to best serve these patients.

Newswise: ‘Disease in a Dish' model sheds light on the triggers for some forms of dementia
Released: 8-Jan-2024 2:05 PM EST
‘Disease in a Dish' model sheds light on the triggers for some forms of dementia
University of Bath

New understanding of a gene that is linked to some forms of dementia and other age-related diseases gives scientists fresh hope that action can be taken against these diseases long before the onset of symptoms.

Released: 8-Jan-2024 12:05 PM EST
High-quality nursing home dementia care is not only a matter of adding staff
University of California, Irvine

Irvine, Calif., Jan. 8, 2024 — Additional staffing alone will not be sufficient to bridge the quality-of-care and health outcome disparities among nursing home facilities with varying percentages of residents with dementia, according to a first-of-its-kind study led by the University of California, Irvine. Specialized training, an easy-to-navigate environment and staff stability are also critical to meeting the unique challenges presented by this population.

2-Jan-2024 10:05 AM EST
Even in Midlife, Disrupted Sleep Tied to Memory, Thinking Problems Later On
American Academy of Neurology (AAN)

People who have more disrupted sleep in their 30s and 40s may be more likely to have memory and thinking problems a decade later, according to new research published in the January 3, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The study does not prove that sleep quality causes cognitive decline. It only shows an association.

Released: 2-Jan-2024 2:05 PM EST
Researchers identify new coding mechanism that transfers information from perception to memory
Dartmouth College

Our memories are rich in detail: we can vividly recall the color of our home, the layout of our kitchen, or the front of our favorite café. How the brain encodes this information has long puzzled neuroscientists.

Newswise: Evidence early, but emerging, that gamma rhythm stimulation can treat neurological disorders
Released: 20-Dec-2023 3:05 PM EST
Evidence early, but emerging, that gamma rhythm stimulation can treat neurological disorders
Picower Institute for Learning and Memory at MIT

A surprising MIT study published in Nature at the end of 2016 helped to spur interest in the possibility that light flickering at the frequency of a particular gamma-band brain rhythm could produce meaningful therapeutic effects for people with Alzheimer’s disease.

Released: 20-Dec-2023 1:05 PM EST
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx
Superfluid Dx

WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ Sciences has acquired majority ownership in the Alzheimer's Disease (AD) diagnostics company, Molecular Stethoscope, Inc., which is now renamed Superfluid Diagnostics, Inc. The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) participated in the Series A financing.

Newswise: Alzheimer’s discovery reveals dire effect of toxic tau protein on brain cells
Released: 20-Dec-2023 12:05 PM EST
Alzheimer’s discovery reveals dire effect of toxic tau protein on brain cells
University of Virginia Health System

University of Virginia Alzheimer’s researchers have discovered how harmful tau proteins damage the essential operating instructions for our brain cells, a finding which could lead to new treatments.

Released: 20-Dec-2023 12:05 PM EST
Digital training program improves quality of life for care residents with dementia – even during the COVID-19 pandemic
University of Exeter

Quality of life for people with dementia living in residential and nursing home care substantially improved after staff took part in a digital training programme that was specially adapted to Covid-19 restrictions. The training also led to a significant drop in the prescription of potentially harmful sedative medications to residents.

Newswise: Caring for loved ones with dementia, Alzheimer's disease during the holidays
Released: 19-Dec-2023 7:05 PM EST
Caring for loved ones with dementia, Alzheimer's disease during the holidays
University of California, Los Angeles (UCLA), Health Sciences

UCLA Health dementia care specialists say caregiving and holiday festivities do not have to be mutually exclusive, but do require some adaptations to make the season enjoyable for all.



close
1.65451